Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer
MONALEESA-2 最新结果,这是一项 III 期临床试验,旨在比较一线利博西尼联合来曲唑与安慰剂联合来曲唑治疗激素受体阳性、HER2 阴性晚期乳腺癌的疗效。
期刊:Annals of Oncology
影响因子:65.4
doi:10.1093/annonc/mdz215
Hortobagyi, G N; Stemmer, S M; Burris, H A; Yap, Y S; Sonke, G S; Paluch-Shimon, S; Campone, M; Petrakova, K; Blackwell, K L; Winer, E P; Janni, W; Verma, S; Conte, P; Arteaga, C L; Cameron, D A; Mondal, S; Su, F; Miller, M; Elmeliegy, M; Germa, C; O'Shaughnessy, J